Allergan taps Twilight star for acne interactive ads

Share this article:

Allergan is tweaking two teen cultural sensations with a High School Musical-themed interactive campaign for its acne medication Aczone, starring Michael Welch of Twilight fame.

Welch plays Mike Newton, the baby-faced would-be human love interest of the heroine in the vampiric teen romance series, the second film installment of which, New Moon, opens this month. He serves as the narrator of Aczone the Musical and featured in a September back-to-school sweepstakes, the winner of which will attend a red carpet event related to the screening of New Moon with Welch.

The campaign, by agency Indelible, uses musical online video vignettes to illustrate the agonies of adolescence and acne. Visitors can also find a dermatologist or get a free sample voucher, and there's an area for parents as well as interactive features allowing teens to “send a love note,” download songs, play games or tell their friends about the site.

Aimed at 14-20 year olds, Aczone the Musical pays winking homage to High School Musical, a Disney phenomenon, launched in 2006, that its audience is presumed to have outgrown somewhat. Welch helps break through the clutter, said an agency spokesperson, and brings just the irreverent, Dennis Leary-esque tone to the effort that the shop was looking for.

Allergan and Indelible promoted the site with banner ads running on Facebook, Yahoo and entertainment networks and reached out to top teen and entertainment-oriented bloggers. The effort will run through the fall.

Allergan was forced to briefly suspend both the brand-dot-com site and aczonethemusical.com in mid-September following an FDA complaint about its consumer messaging, though the agency's beef was chiefly with language on aczone.com, and few changes were required of aczonethemusical.com, the agency said. FDA had objected in August to a journal ad for the medication. Launched last November, Aczone was the first Rx acne medication approved in 10 years.

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.